ChabiotechLtd Balance Sheet Health
Financial Health criteria checks 4/6
ChabiotechLtd has a total shareholder equity of ₩656.3B and total debt of ₩395.2B, which brings its debt-to-equity ratio to 60.2%. Its total assets and total liabilities are ₩1,725.6B and ₩1,069.2B respectively.
Key information
60.2%
Debt to equity ratio
₩395.23b
Debt
Interest coverage ratio | n/a |
Cash | ₩221.79b |
Equity | ₩656.33b |
Total liabilities | ₩1.07t |
Total assets | ₩1.73t |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A085660's short term assets (₩538.2B) do not cover its short term liabilities (₩646.2B).
Long Term Liabilities: A085660's short term assets (₩538.2B) exceed its long term liabilities (₩423.1B).
Debt to Equity History and Analysis
Debt Level: A085660's net debt to equity ratio (26.4%) is considered satisfactory.
Reducing Debt: A085660's debt to equity ratio has increased from 23.2% to 60.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A085660 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A085660 has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 22.2% each year.